Extensive ongoing research across the Europe to identify new treatments for eye diseases is likely to favor the vision care market growth in the coming years. The institute also funds trials to develop cutting-edge therapies for blinding diseases. In 2017, the NEI launched a 3D Retina Organoid Challenge Competition (3D-ROC) to develop functioning mini-retinas from human stem cells. It announced the prize money of US$ 1.1 million to the team with the best replication of retina structure and function.
The Karolinska Institutet, Sweden, offers grants to promote research on eye diseases. In 2020, the institute announced SEK 50,000–150,000 (US$ 5,912.88–17,738.64) per person funding for new research projects on eye diseases. These funds will be used to provide maximum flexibility in developing and expanding eye research programs and fostering creative planning beyond the scope of restricted project grants. Thus, increasing funds for eyecare research are likely to bring new trends in the vision care market to trigger its growth.
The European vision care market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the vision care market. The European vision care market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing prevalence of eye disease and diabetes, launch of innovative products by market players in the region.
Strategic insights for the Europe Vision Care provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Vision Care refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Europe Vision Care Strategic Insights
Europe Vision Care Report Scope
Report Attribute
Details
Market size in 2022
US$ 23,743.83 Million
Market Size by 2028
US$ 31,199.09 Million
Global CAGR (2022 - 2028)
4.7%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type
By Distribution Channel
Regions and Countries Covered
Europe
Market leaders and key company profiles
Europe Vision Care Regional Insights
The Europe vision care market is segmented based on type, distribution channel, and country. Based on type, the Europe vision care market is segmented into eyeglasses, contact lens, intraocular lens, and others. The eyeglasses segment held the largest market share in 2022.
Based on distribution channel, the Europe vision care market is segmented into retail stores, e-commerce, clinics, and hospitals. The retail stores segment held the largest market share in 2022.
Based on country, the Europe vision care market is segmented into Germany, the UK, Spain, Italy, France, and the Rest of Europe. Germany dominated the Europe vision care market share in 2022.
Alcon Inc.; Bausch Health Companies Inc.; Carl Zeiss AG; Cooper Companies Inc; Essilor International SAS; Johnson & Johnson; Hoya Corp; Rodenstock GMBH; Menicon Co., Ltd; and Rayner Intraocular Lenses Limited are the leading companies operating in the Europe vision care market.
The Europe Vision Care Market is valued at US$ 23,743.83 Million in 2022, it is projected to reach US$ 31,199.09 Million by 2028.
As per our report Europe Vision Care Market, the market size is valued at US$ 23,743.83 Million in 2022, projecting it to reach US$ 31,199.09 Million by 2028. This translates to a CAGR of approximately 4.7% during the forecast period.
The Europe Vision Care Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Vision Care Market report:
The Europe Vision Care Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Vision Care Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Vision Care Market value chain can benefit from the information contained in a comprehensive market report.